Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114024A1 Method for promoting the formation of secondary cell wall of plant
10/07/2010WO2010113039A1 Mutants of activation-induced cytidine deaminase (aid) and methods of use
10/07/2010WO2010112678A1 Regenerative matrix comprising cells activated by nemosis and/or factors released from such cells
10/07/2010WO2010112662A1 Multipotent stem cells derived from mesenteric stroma
10/07/2010WO2010112212A1 Method for the generation of a skin model and skin model
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010090843A3 Gingiva derived stem cell and its application in immunomodulation and reconstruction
10/07/2010WO2010080985A8 Compositions and methods for induced brown fat differentiation
10/07/2010WO2010079510A3 Anti-rhd monoclonal antibodies
10/07/2010WO2010059965A3 Methods and compositions for generating self attenuating genetic circuitry
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100257638 Zinc finger nuclease-mediated homologous recombination
10/07/2010US20100257637 Transgenic Plant with Increased Stress Tolerance and Yield
10/07/2010US20100257636 Plant biochemical systems and uses thereof
10/07/2010US20100257631 Soybean variety g00-3209
10/07/2010US20100257623 Herbicide Resistant Rice
10/07/2010US20100257620 Transgenic animals for assessing drug metabolsim and toxicity
10/07/2010US20100257619 mTOR Ligands and Polynucleotides Encoding mTOR Ligands
10/07/2010US20100257616 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
10/07/2010US20100256756 Sericin extracted fabrics
10/07/2010US20100256332 GLP-1 Fusion Peptides, Their Production and Use
10/07/2010US20100256240 Prostacyclin derivatives
10/07/2010US20100256234 Method for Stimulating the Proliferation of Differentiated Cells Belonging to the Chondrogenic Lineage
10/07/2010US20100256226 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100256222 Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256098 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods
10/07/2010US20100256093 Methods of and compositions for reducing cell death
10/07/2010US20100256040 Composition and method for treating viral infection
10/07/2010US20100256038 Th-17 cells
10/07/2010US20100256014 Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
10/07/2010US20100255999 Cell Co-Culture Systems and Uses Thereof
10/07/2010US20100255608 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
10/07/2010US20100255586 Methods and compositions for producing vitamin k dependent proteins
10/07/2010US20100255585 Plant stem cell line derived from quiescent center and method for isolating the same
10/07/2010US20100255584 Arabidopsis thaliana Genome Sequence and Uses Thereof
10/07/2010US20100255583 TiO2 nanostructures, membranes and films, and applications of same
10/07/2010US20100255582 Deformable transportable bioreactor chamber
10/07/2010US20100255581 Stimuli responsive nanofibers
10/07/2010US20100255580 Differentiation of Human Embryonic Stem Cells
10/07/2010US20100255579 Tumor antigen protein and use thereof
10/07/2010US20100255578 Method of producing lymphocytes
10/07/2010US20100255577 Use of a new isolate of neospora caninum for the development of diagnostic tests and for preparation of products for treatment and prevention of the infection caused by neospora
10/07/2010US20100255576 Cell culture methods and devices utilizing gas permeable materials
10/07/2010US20100255575 Identification and Isolation of Acute Myeloid Leukemia Stem Cells
10/07/2010US20100255574 Human Secreted Proteins
10/07/2010US20100255573 Extraction and purification of biologigal cells using ultrasound
10/07/2010US20100255572 Inflammation-induced anti-flammatory gene expression
10/07/2010US20100255571 Method and device for fixing/stabilising a sample
10/07/2010US20100255550 Regulatory Factors Controlling Oil Biosynthesis In Microalgae And Their Use
10/07/2010US20100255549 Microbial production of 3-hydroxyacids from glucose and glycolate
10/07/2010US20100255545 Integrated - ligand-responsive micrornas
10/07/2010US20100255539 Engineered Antibody-Stress Protein Fusions
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255535 Novel gene upregulated in cancers of the prostate
10/07/2010US20100255524 Method for stabilising a biological sample
10/07/2010US20100255515 Elisa for vegf
10/07/2010US20100255505 Genetically modified stem cells and methods for identifying tissues differentiated therefrom
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255496 Methods of isolating cells and generating monoclonal antibodies
10/07/2010US20100255447 Advanced bio-compatible polymer surface coatings for implants and tissue engineering scaffolds
10/07/2010US20100255112 Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
10/07/2010US20100255111 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
10/07/2010US20100255075 CR-2 Binding Peptide P28 as Molecular Adjuvant for DNA Vaccines
10/07/2010US20100255065 Method for differenciating mesenchymal stem cell and culturing chondrocytes using alginate coated fibrin/ha composite scaffold
10/07/2010US20100255059 Artificial micro-gland
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255043 Methods for preparing T-cells for cell therapy
10/07/2010US20100255037 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
10/07/2010US20100255023 Dendritic cell vaccine compositions and uses of same
10/07/2010US20100255020 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducers, and pharmaceutical compositions and vaccines employing them
10/07/2010US20100255018 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255012 Recombinant fucose modified monovalent half-antibodies obtained by molecular engineering
10/07/2010US20100255010 Anti-her antibodies
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255008 Antibodies against human tweak and uses thereof
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255004 Receptor tyrosine kinase profiling
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254987 Engineered proteins with high affinity for dota chelates
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254977 Engineered anti-alpha v-integrin hybrid antibodies
10/07/2010US20100254975 Alpha-4 beta-7 heterodimer specific
10/07/2010US20100254958 Antigen-Specific T-Cell Preparations from Bone Marrow
10/07/2010US20100254955 Surgical device for skin therapy or testing
10/07/2010US20100254954 Human Bone Stem Cells From Amniotic Mesenchymal Cell Layer
10/07/2010US20100254953 Cell growth method and pharmaceutical preparation for tissue repair and regeneration
10/07/2010US20100254952 Isolated myeloid-like cell populations and methods of treatment therewith
10/07/2010US20100254951 Nerve Regeneration Promoting Agent
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010CA2757613A1 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
10/07/2010CA2757538A1 Tissue and organ graft bioreactor and method of operation
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 1827